Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

Fisher, B; Dignam, J; Wolmark, N; Wickerham, D L; Fisher, E R; Mamounas, E; Smith, R; Begovic, M; Dimitrov, N V; Margolese, R G; Kardinal, C G; Kavanah, M T; Fehrenbacher, L; Oishi, R H

Fisher, B; Dignam, J; Wolmark, N; Wickerham, D L; Fisher, E R; Mamounas, E; Smith, R; Begovic, M; Dimitrov, N V; Margolese, R G; Kardinal, C G; Kavanah, M T; Fehrenbacher, L; Oishi, R H.

Affiliation

Fisher B; National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212-5234, USA. bfisher@aherf.edu

Lancet ; 353(9169): 1993-2000, 1999 Jun 12.

Article in En | MEDLINE | ID: mdl-10376613

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/drug therapy; Carcinoma, Intraductal, Noninfiltrating/drug therapy; Tamoxifen/therapeutic use; Antineoplastic Agents, Hormonal/adverse effects; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Breast Neoplasms/therapy; Carcinoma in Situ/drug therapy; Carcinoma in Situ/therapy; Carcinoma, Intraductal, Noninfiltrating/mortality; Carcinoma, Intraductal, Noninfiltrating/secondary; Carcinoma, Intraductal, Noninfiltrating/therapy; Carcinoma, Lobular/drug therapy; Carcinoma, Lobular/therapy; Combined Modality Therapy; Double-Blind Method; Female; Humans; Mastectomy, Segmental; Middle Aged; Survival Rate; Tamoxifen/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Carcinoma, Intraductal, Noninfiltrating / Antineoplastic Agents, Hormonal Type of study: Clinical_trials Limits: Female / Humans / Middle aged Language: En Journal: Lancet Year: 1999 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links